Overview
Genus plc is a leading biotechnology company based in the United Kingdom, primarily known for its pioneering work in animal genetics. The company operates globally, providing genetically superior pig and cattle breeding stock, along with state-of-the-art reproductive technologies to the livestock industry. A key focus of Genus plc is on developing genetic solutions to help farmers improve the efficiency and sustainability of their herds. Its major projects include advancements in porcine and bovine reproduction, notably through the use of proprietary gene editing technologies and genomically enhanced breeding programs. These cutting-edge initiatives aim not only to increase farm profitability but also to address broader challenges such as food security and environmental impacts associated with traditional farming practices.
AI+ Ask Fintel’s AI assistant about Genus plc - Depositary Receipt (Common Stock).
Thinking about good questions…
Basic Stats
The share price of Genus plc - Depositary Receipt (Common Stock) as of May 14, 2024 is $25.60 / share.
The Factor Analysis chart (below right) shows a view of Genus plc - Depositary Receipt (Common Stock) from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 65.97 MM |
| Earnings Date | |
| EPS (TTM) | 0.29 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-03-10 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.02 |
| ROE | 0.04 |
| ROIC | 0.03 |
| CROIC | 0.01 |
| OCROIC | 0.09 |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Genus plc - Depositary Receipt (Common Stock). An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-05-16 | Peel Hunt Limited | Buy | Reiterate | |
| 2022-04-12 | Peel Hunt Limited | Hold | Reiterate | |
| 2021-12-07 | Liberum Capital | Reiteration | Reiterate | |
| 2021-11-24 | Liberum Capital | Reiteration | Reiterate | |
| 2021-11-03 | Liberum Capital | Buy | Reiterate | |
| 2021-09-09 | Liberum Capital | Buy | Reiterate | |
| 2021-06-29 | Citigroup | Hold | Reiterate | |
| 2021-06-29 | Numis | Add | Reiterate | |
| 2021-06-23 | Liberum Capital | Buy | Reiterate | |
| 2021-06-22 | Peel Hunt LLP | Buy | Reiterate | |
| 2021-01-18 | Liberum Capital | Buy | Reiterate | |
| 2019-11-14 | Liberum Capital | Buy | Reiterate | |
| 2019-11-14 | Peel Hunt LLP | Buy | Reiterate | |
| 2019-09-11 | Peel Hunt LLP | Buy | Reiterate | |
| 2019-08-22 | Peel Hunt LLP | Buy | Reiterate | |
| 2019-02-28 | Liberum Capital | Hold | Reiterate | |
| 2018-06-21 | Peel Hunt LLP | Buy | Reiterate | |
| 2018-03-01 | Berenberg Bank | Hold | Reiterate | |
| 2017-04-03 | N+1 Singer | Hold | Reiterate | |
| 2017-03-23 | Berenberg Bank | Hold | Initiate | |
| 2017-02-23 | N+1 Singer | Hold | Reiterate | |
| 2016-08-04 | HSBC | Buy | Reiterate | |
| 2016-03-10 | N+1 Singer | Hold | Reiterate | |
| 2015-11-19 | N+1 Singer | Hold | Reiterate | |
| 2015-11-19 | Peel Hunt LLP | Buy | Reiterate | |
| 2015-09-11 | HSBC | Buy | Reiterate | |
| 2015-05-12 | Numis Securities | Hold | Reiterate | |
| 2015-02-24 | Numis Securities | Add | Reiterate | |
| 2015-01-12 | Liberum Capital | Buy | Reiterate | |
| 2014-12-15 | Liberum Capital | Buy | Reiterate | |
| 2014-11-24 | Liberum Capital | Buy | Reiterate | |
| 2014-11-17 | Numis Securities | Add | Reiterate | |
| 2014-11-14 | Liberum Capital | Buy | Reiterate | |
| 2014-11-14 | Peel Hunt LLP | Buy | Reiterate | |
| 2014-11-03 | Liberum Capital | Buy | Reiterate | |
| 2014-09-12 | Numis Securities | Add | Reiterate | |
| 2014-09-10 | N+1 Singer | Buy | Reiterate | |
| 2014-08-26 | Liberum Capital | Buy | Reiterate | |
| 2014-08-21 | Numis Securities | Add | Initiate | |
| 2014-08-11 | Liberum Capital | Buy | Reiterate | |
| 2014-06-09 | Liberum Capital | Buy | Reiterate | |
| 2014-06-06 | N+1 Singer | Hold | Reiterate | |
| 2014-05-27 | N+1 Singer | Hold | Reiterate | |
| 2014-05-15 | N+1 Singer | Hold | Reiterate | |
| 2014-04-01 | Panmure Gordon | Sell | Reiterate | |
| 2014-03-17 | Liberum Capital | Buy | Reiterate | |
| 2014-02-27 | Liberum Capital | Buy | Reiterate | |
| 2014-02-26 | Panmure Gordon | Sell | Reiterate | |
| 2014-02-25 | N+1 Singer | Hold | Reiterate | |
| 2014-02-19 | Panmure Gordon | Sell | Reiterate | |
| 2013-12-04 | N+1 Singer | Hold | Reiterate | |
| 2013-11-15 | N+1 Singer | Hold | Reiterate | |
| 2013-10-01 | N+1 Singer | Hold | Reiterate | |
| 2013-09-05 | Liberum Capital | Buy | Reiterate | |
| 2024-07-17 | Deutsche | Buy | Reiterate | |
| 2024-11-22 | Shore Capital | Not Rated | Reiterate | |
| 2025-07-15 | Shore Capital | Buy | Reiterate | |
| 2024-12-11 | Shore Capital | Buy | Reiterate | |
| 2025-07-15 | Deutsche | Buy | Reiterate | |
| 2025-09-04 | Shore Capital | Buy | Reiterate | |
| 2025-04-30 | Shore Capital | Buy | Reiterate | |
| 2025-08-21 | Shore Capital | Buy | Reiterate |
